Repligen Corp. (RGEN)

142.18 +2.52 (+1.80%) USD  |  NASDAQ  |  Feb 06, 16:00
142.13 -0.05 (-0.04%) After-Hours: 20:00
More

Repligen Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Enovis Corp. Upgrade
Abbott Laboratories Upgrade
Accuray, Inc. Upgrade
Alphatec Holdings, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade